24/7 Patient Assistance: 760-405-8205

Johann Brandes, MD,PhD, FCCP

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information
  • Education & Training


    Ludwig Maximilian University of Munich Faculty of Medicine

    Medical School


    Johns Hopkins University



    Johns Hopkins University


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Saint Thomas - Rutherford Hospital

    Languages: English/Spanish

    (615) 396-4100

    1700 Medical Center Pkwy

    Murfreesboro, Tennessee 37129

    Read More
  • Publications & Memberships

    Dr. Johann Brandes has contributed to 3 publications.

    Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.

    Brodie SA, Li G, Harvey D, Khuri FR, Vertino PM, Brandes JC; Oncotarget. 2015 Oct 13.

    See more >>

    Class I HDACs are mediators of smoke-carcinogen induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.

    Brodie SA Li G El-Kommos A Kang H Ramalingam SS Behera M Gandhi K Kowalski J Sica GL Khuri FR Vertino PM Brandes JC; Cancer Prev Res (Phila). 2014 Jan 17 .

    See more >>

    Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.

    Brodie SA Li G Brandes JC; Respir Med. 2014 Nov 21 .

    See more >>